After a slight hiccup disrupted weeks of improvement, the medtech industry again flexed its muscles over the last seven days. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 20) at 119.63 points, representing a 1.5% rise from the 117.92-point tally set a week prior. […]
Alcon
Alcon reports 74% sales growth in Q2, raises 2021 guidance
Alcon (NYSE:ALC) this week posted second-quarter results that beat the overall consensus on Wall Street and raised its full-year guidance. The Geneva-based eye care company reported profits of $151 million, or 31¢ per share, on sales of $2.1 billion for the three months ended June 30, for a sales growth of 74.79% compared with Q2 2020. […]
Alcon inks U.S. selling rights for BlephEx’s eyelid cleaning device
Alcon announced last week that it agreed to a partnership providing it exclusive rights to sell the BlephEx technology and accompanying products. BlephEx’s eyelid cleaning device and the LashCam iR WiFi camera are set to join Alcon’s Systane iLux technology to meet the ocular surface health needs of patients in an office setting, according to […]
Alcon dips despite Q1 earnings beat
Alcon (NYSE:ALC) stock is down today, even after the company reported first-quarter results that beat the consensus forecast. The Geneva, Switzerland-based company posted earnings per share of 17¢ on sales of $1.9 billion for the three months ended March 31, 2021, registering revenue growth of 4.8% year-over-year. Adjusted to exclude one-time items, earnings per share […]
8 medical device companies that beat the COVID-19 pandemic and prospered
Some medical device businesses not only survived the COVID-19 pandemic but actually thrived — with many producing the medtech needed to fight the coronavirus’s spread. Medical Design & Outsourcing recently analyzed financials for 20 of the largest medical device businesses in the world. Not only was revenue only slightly down for the 20 during 2020, but it was […]
How big medtech fared during a year of COVID-19
Despite numerous challenges, the medtech industry showed itself to be fairly recession-proof in 2020, according to a Medical Design & Outsourcing/MassDevice analysis of financials. Annual reports recently released by 20 of the world’s largest medical device companies showed only a slight dip in revenue during 2020 — a year in which medtech held the front lines against […]
Alcon launches extended depth of focus intraocular lens
Alcon (NYSE:ALC) announced today that it launched the first and only non-diffractive extended depth of focus intraocular lens in the U.S. Geneva, Switzerland-based Alcon’s AcrySof IQ Vivity IOL, a presbyopia-mitigating lens, is now available to all U.S. ophthalmologists for use with patients who are undergoing cataract surgery, according to a news release. AcrySof IQ Vivity uses […]
The 20 largest medical device companies in the world
The information in this year’s annual Big 100 rankings of the world’s largest medical device companies is as interesting as ever. The 100 companies on this year’s list had medical device businesses bringing in a whopping $420.5 billion during their most recent fiscal years — a nearly 6% increase from the 2019 Big 100. But […]
Diversity in medtech: Just 20% of executive roles held by women
Diversity in executive roles in the medical device industry is trending more toward parity, with women holding 2% more C-suite roles in 2020 compared to last year. Just 20% of executives at the 100 largest medical device companies in the world are women, and those companies average 19% female composition in the C-suite, according to […]
Alcon slides on missed Q2 earnings
Alcon (NYSE:ALC) shares dipped before hours today on second-quarter results that missed the consensus earnings forecast. The Geneva, Switzerland-based company posted losses of -$422 million, or -86¢ per share, on sales of $1.2 billion for the three months ended June 30, 2020, for an 8.2% bottom-line slide on a sales decline of -36.2%. Adjusted to exclude […]
Novartis, Alexion charged with FPCA violations
Novartis (NYSE:NVS) and Alexion Pharmaceuticals (NSDQ:ALXN) were charged with violations of the books and records and internal accounting controls provisions of the Foreign Corrupt Practices Act (FCPA). The Securities & Exchange Commission (SEC) announced that the pharmaceutical companies both committed violations and both agreed to pay millions of dollars to settle the charges. Novartis settled to pay over […]
